A study conducted on a Japanese population that also had heterogeneous characteristics regarding disease stage and further treatment received by the patients, adopting the same criteria for the classification of receptors of the EGFR family as used in the present study but without immunohistochemical evaluation by TMA, suggested that HER3 may also have a prognostic influence on gastric cancer [14]. This evidence concerns the gene ERBB3 and gastric cancer.